AI Could Predict Cognitive Decline Leading to Alzheimerās Disease in the Next 5 Years
A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimerās disease.
Dr. Mallar Chakravarty, a computational neuroscientist at the Douglas Mental Health University Institute, and his colleagues from the University of Toronto and the Centre for Addiction and Mental Health, designed an algorithm that learns signatures from magnetic resonance imaging (MRI), genetics, and clinical data. This specific algorithm can help predict whether an individualās cognitive faculties are likely to deteriorate towards Alzheimerās in the next five years.
āAt the moment, there are limited ways to treat Alzheimerās and the best evidence we have is for prevention. Our AI methodology could have significant implications as a ādoctorās assistantā that would help stream people onto the right pathway for treatment. For example, one could even initiate lifestyle changes that may delay the beginning stages of Alzheimerās or even prevent it altogether,ā says Chakravarty, an Assistant Professor in ŗ«¹śĀćĪčās Department of Psychiatry.
The findings, published in, used data from the Alzheimerās Disease NeuroImaging Initiative. The researchers trained their algorithms using data from more than 800 people ranging from normal healthy seniors to those experiencing mild cognitive impairment, and Alzheimerās disease patients. They replicated their results within the study on an independently collected sample from the Australian Imaging and Biomarkers Lifestyle Study of Ageing.
Can the predictions be improved with more data?
āWe are currently working on testing the accuracy of predictions using new data. It will help us to refine predictions and determine if we can predict even farther into the future,ā says Chakravarty. With more data, the scientists would be able to better identify those in the population at greatest risk for cognitive decline leading to Alzheimerās.
According to the Alzheimer Society of Canada, 564,000 Canadians had Alzheimerās or another form of dementia in 2016. The figure will rise to 937,000 within 15 years.
Worldwide, around 50million people have dementia and the total number is projected to reach 82million in 2030 and 152 in 2050, according to the World Health Organization. Alzheimerās disease, the most common form of dementia, may contribute to 60ā70% of cases. Presently, there is no truly effective treatment for this disease.
This work was funded by the Canadian Institutes of Health Research, the Natural Sciences andEngineering Research Council of Canada, the Fonds de recherche du QuĆ©becāSantĆ©, Weston Brain Institute, Michael J. Fox Foundation for Parkinsonās Research, Alzheimerās Society, Brain Canada, and the ŗ«¹śĀćĪč Healthy Brains for Healthy Lives - Canada First Research Excellence Fund.
The article āā was published in PLOS Computational Biology
For information and interviews
Bruno Geoffroy
Press Information Officer - Media Relations Office
CIUSSS de lāOuest-de-lāĆle-de-MontrĆ©al (Douglas Mental Health University Institute)
Tel.: 514-630-2225, ext. 5257